Literature DB >> 16827126

Molecular mechanisms of (-)-gossypol-induced apoptosis in human prostate cancer cells.

Yi-Wen Huang1, Li-Shu Wang, Hsiang-Lin Chang, Weiping Ye, Michael K Dowd, Peter J Wan, Young C Lin.   

Abstract

BACKGROUND: Gossypol, a natural compound present in cottonseeds, displays antiproliferative and pro-apoptotic effects against various cancer cells. The (-)-gossypol enantiomer is a more potent inhibitor of cancer cell growth. Here, the molecular mechanisms of apoptosis induced by (-)-gossypol were studied in human prostate cancer cells.
MATERIALS AND METHODS: After the prostate cancer cell DU-145 had been treated with (-)-gossypol, the trypan blue exclusion assay and DNA fragment end-labeling assay were used to stain the dead cells and to detect DNA laddering, respectively. The effects of (-)-gossypol on the expression of apoptotic-regulated gene markers in both death receptor- and mitochondria-mediated apoptotic pathways, such as the Bcl-2 family and caspase, etc., were detected by RT-PCR and Western blot analysis. To further investigate the apoptotic pathways induced by (-)-gossypol, different caspase inhibitors were used to block caspase activities and cell viability was detected by the CellTiter 96 AQueous assay in DU-145 cells.
RESULTS: At a 5-10 microM dose-level, (-)-gossypol significantly enhanced apoptosis measured by DNA fragmentation. (-)-Gossypol caused apoptosis in DU-145 cells through the down-regulation of Bcl-2 and Bcl-xL and the up-regulation of Bax at the mRNA and protein levels. (-)-Gossypol also activated caspases-3, -8 and -9 and increased PARP [poly (ADP-ribose) polymerase] cleavage. Furthermore, (-)-gossypol-induced apoptosis might be due to an increase in CAD (caspase-activated deoxyribonuclease) proteins and a decrease in ICAD (inhibitor of CAD) proteins. By using caspase inhibitors, (-)-gossypol caused apoptosis via the caspase-dependent pathways.
CONCLUSION: Our results indicated that the apoptotic processes caused by (-)-gossypol are mediated by the regulation of the Bcl-2 and caspase families in human prostate cancer cells. Our data also suggested that (-)-gossypol may have chemotheraputic benefits for prostate cancer patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16827126

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  17 in total

1.  Small molecule inhibition of the steroid receptor coactivators, SRC-3 and SRC-1.

Authors:  Ying Wang; David M Lonard; Yang Yu; Dar-Chone Chow; Timothy G Palzkill; Bert W O'Malley
Journal:  Mol Endocrinol       Date:  2011-11-03

Review 2.  Small-molecule inhibitors reveal a new function for Bcl-2 as a proangiogenic signaling molecule.

Authors:  Benjamin D Zeitlin; Jacques E Nör
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

3.  Inhibition of proliferation of prostate cancer cell line, PC-3, in vitro and in vivo using (-)-gossypol.

Authors:  Xian-Qing Zhang; Xiao-Feng Huang; Shi-Jie Mu; Qun-Xing An; Ai-Jun Xia; Rui Chen; Dao-Cheng Wu
Journal:  Asian J Androl       Date:  2010-01-18       Impact factor: 3.285

4.  Poly(ethylene glycol)-block-poly(ε-caprolactone) micelles for combination drug delivery: evaluation of paclitaxel, cyclopamine and gossypol in intraperitoneal xenograft models of ovarian cancer.

Authors:  Hyunah Cho; Tsz Chung Lai; Glen S Kwon
Journal:  J Control Release       Date:  2012-12-13       Impact factor: 9.776

5.  Overcoming drug resistance in hormone- and drug-refractory prostate cancer cell line, PC-3 by docetaxel and gossypol combination.

Authors:  Ercument Cengiz; Burcak Karaca; Yuksel Kucukzeybek; Gurbuz Gorumlu; Mustafa K Gul; Cigdem Erten; Harika Atmaca; Selim Uzunoglu; Bulent Karabulut; Ulus A Sanli; Ruchan Uslu
Journal:  Mol Biol Rep       Date:  2009-03-14       Impact factor: 2.316

Review 6.  Expanding circle of inhibition: small-molecule inhibitors of Bcl-2 as anticancer cell and antiangiogenic agents.

Authors:  Benjamin D Zeitlin; Isaac J Zeitlin; Jacques E Nör
Journal:  J Clin Oncol       Date:  2008-09-01       Impact factor: 44.544

7.  Small molecule inhibitors of bcl-2 family proteins for pancreatic cancer therapy.

Authors:  Ashiq Masood; Asfar S Azmi; Ramzi M Mohammad
Journal:  Cancers (Basel)       Date:  2011-06-01       Impact factor: 6.639

8.  Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathway.

Authors:  Tao Ren; Jinlu Shan; Yi Qing; Chengyuan Qian; Qing Li; Guoshou Lu; Mengxia Li; Chongyi Li; Yu Peng; Hao Luo; Shiheng Zhang; Weiwei Zhang; Dong Wang; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2014-12-12       Impact factor: 4.162

9.  Identification of a novel potential antitumor activity of gossypol as an APE1/Ref-1 inhibitor.

Authors:  Chengyuan Qian; Mengxia Li; Jiangdong Sui; Tao Ren; Zheng Li; Liang Zhang; Liwei Zhou; Yi Cheng; Dong Wang
Journal:  Drug Des Devel Ther       Date:  2014-05-09       Impact factor: 4.162

10.  Mobilization of Intracellular Copper by Gossypol and Apogossypolone Leads to Reactive Oxygen Species-Mediated Cell Death: Putative Anticancer Mechanism.

Authors:  Haseeb Zubair; Shafquat Azim; Husain Yar Khan; Mohammad Fahad Ullah; Daocheng Wu; Ajay Pratap Singh; Sheikh Mumtaz Hadi; Aamir Ahmad
Journal:  Int J Mol Sci       Date:  2016-06-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.